Author + information
- Received March 30, 2020
- Revision received April 2, 2020
- Accepted April 2, 2020
- Published online June 15, 2020.
- Pinak B. Shah, MDa,b,∗ (, )
- Frederick G.P. Welt, MDa,c,
- Ehtisham Mahmud, MDd,e,
- Alistair Phillips, MDf,g,
- Neal S. Kleiman, MDa,h,
- Michael N. Young, MDa,i,
- Matthew Sherwood, MD, MHSa,j,
- Wayne Batchelor, MDa,j,
- Dee Dee Wang, MDk,
- Laura Davidson, MDa,l,
- Janet Wyman, DNP, APRNa,k,
- Sabeeda Kadavath, MDa,m,
- Molly Szerlip, MDd,n,
- James Hermiller, MDd,o,
- David Fullerton, MDf,p,
- Saif Anwaruddin, MDa,q,
- on behalf of American College of Cardiology and the Society for Cardiovascular Angiography and Interventions
- aAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC
- bDivision of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
- cCardiovascular Division, University of Utah Health, Salt Lake City, Utah
- dSociety for Cardiovascular Angiography and Interventions, Washington, DC
- eDivision of Cardiovascular Medicine, University of California-San Diego, San Diego, California
- fAmerican College of Cardiology Cardiac Surgery Team and Leadership Council, Washington, DC
- gThe Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio
- hCardiovascular Division, Houston Methodist Hospital, Houston, Texas
- iCardiovascular Division, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
- jDivision of Cardiology, Inova Heart and Vascular Institute, Fairfax, Virginia
- kHenry Ford Health System, Center for Structural Heart Disease, Wayne State University School of Medicine, Detroit, Michigan
- lBluhm Cardiovascular Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
- mDepartment of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
- nBaylor Scott and White, The Heart Hospital Plano, Plano, Texas
- oAscension Medical Group, Indianapolis, Indiana
- pDivision of Cardiothoracic Surgery, University of Colorado School of Medicine, Denver, Colorado
- qCardiovascular Division, The Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania
- ↵∗Address for correspondence:
Dr. Pinak B. Shah, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis Street, Boston, Massachusetts 02115.
The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.
This paper is being published simultaneously in Catheterization and Cardiovascular Interventions and JACC: Cardiovascular Interventions.
Dr. Shah is a proctor for Edwards Lifesciences; and has received educational grants from Edwards Lifesciences, Medtronic, and Abbott. Dr. Welt is a site principal investigator for a multicenter trial supported by Medtronic; and is on the advisory board for Medtronic. Dr. Mahmud is a consultant for Abiomed, Medtronic, and Boston Scientific; and chairs multiple data and safety monitoring boards. Dr. Kleiman has received research grants from Medtronic; and serves on steering committees for the PROTECTED TAVR study, sponsored by Boston Scientific, and the PORTICO NG study, sponsored by Abbott. Dr. Sherwood is a consultant for Medtronic. Dr. Batchelor is a consultant for V Wave Medical and Abbott; and is on the Speakers Bureau for Boston Scientific, Medtronic, and Abbott. Dr. Wang is a consultant for Edwards Lifesciences, Materialise, and Boston Scientific; and received grant support from Boston Scientific. Dr. Wyman is a consultant for Edwards Lifesciences and Boston Scientific. Dr. Szerlip is a consultant and proctor for Edwards Lifesciences; is a consultant for Medtronic; and is a consultant and member of the Speakers Bureau for Boston Scientific. Dr. Hermiller is a consultant for Medtronic, Edwards Lifesciences, and Abbott. Dr. Anwaruddin is on the advisory board for Medtronic; is a consultant and proctor for Medtronic and Edwards Lifesciences; is on the steering committee for Boston Scientific; and is a proctor for V Wave Medical.
The views expressed in this paper by the ACC Interventional Council, SCAI, and ACC Cardiac Surgery Team and Leadership Council do not necessarily reflect the view of the Journal of the American College of Cardiology or Catheterization and Cardiovascular Interventions.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Interventions author instructions page.
- Received March 30, 2020.
- Revision received April 2, 2020.
- Accepted April 2, 2020.
- 2020 American College of Cardiology Foundation